Clinical trial
A Prospective, Multi-Center, Single-Arm Clinical Study of the Pristine™ Long-Term Hemodialysis Catheter
NCT05228132 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Single-Arm Clinical Study of the Pristine™ Long-Term Hemodialysis Catheter
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 16, 2022
- Completion date
- September 21, 2022
- Enrollment
- 142 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
central venous catheter related bloodstream infection, end stage renal disease, hemodialysis access failure, hemodialysis catheter infection, hemodialysis complication, kidney failure, chronic